Aykut Uren, MD
Cancer Recurrence Drug Discovery & Development
Professor, Department of Oncology, Department of Biochemistry and Molecular & Cellular Biology, Lombardi Comprehensive Cancer Center, Georgetown University.
Dalit Barkan, PhD
Cancer Recurrence Drug Discovery
Head, Laboratory of Tumor Dormancy and Metastasis, Department of Human Biology and Medical Sciences, Faculty of Natural Sciences, University of Haifa, Israel.
George Sledge, MD
Chief of Oncology, Department of Medicine, Stanford University. Former president of the American Society for Clinical Oncology.
Gil Ben Menachem, PhD
Product Innovation, Business Development and Strategy
Experienced biopharma executive. CEO, Neuromagen Pharma, Teva, Dexcel, Kitov, Paramount Bio and the NIH.
Mike Ihnat, PhD
Cancer Recurrence Biology & Drug Discovery
Associate Professor, Pharmacology, Department of Pharmaceutical Sciences University of Oklahoma College of Pharmacy, OK